Aromatase: A key molecule in the pathophysiology of endometriosis and a therapeutic target

Fertility and Sterility

Volumn 72, Issue 6, 1999, Pages 961-969

  Zeitoun, Khaled M ^a   Bulun, Serdar E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

17 hydroxysteroid dehydrogenase type 2; Aromatase; Aromatase inhibitor; Endometriosis; Endometrium; Estrogen; Progesterone

Indexed keywords

AROMATASE; AROMATASE INHIBITOR;

DRUG USE; ENDOMETRIOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; PATHOPHYSIOLOGY; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TREATMENT INDICATION;

AROMATASE; AROMATASE INHIBITORS; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME INHIBITORS; EPITHELIAL CELLS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; STROMAL CELLS;

EID: 0032753959     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00393-3     Document Type: Review

References (89)

1. Vessey M.P., Villard-Mackintosh L., Painter R. Epidemiology of endometriosis in women attending family planning clinics. Br Med J. 306:1993;182-184.
2. Houston D.E., Noller K., Melton L.J., Selwyn B.J. The epidemiology of pelvic endometriosis. Clin Obstet Gynecol. 31:1988;787-800.
3. Kjerulff K.H., Erickson B.A., Langenberg P.W. Chronic gynecological conditions reported by US women findings from the National Health Information Survey, 1984 to 1992 . Am J Public Health. 86:1996;195-199.
4. Aral S.O., Cates W. Jr. The increasing concern with infertility why now? J Am Med Assoc. 250:1983;2327-2331.
5. Hasson H.M. Incidence of endometriosis in diagnostic laparoscopy. J Reprod Med. 16:1976;135-138.
6. Kempers R.D., Dockerty M.B., Hunt A.B. Significant postmenopausal endometriosis. Surg Gynecol Obstet. 111:1960;348-356.
7. Punnonen R., Klemi P., Nikkanen V. Postmenopausal endometriosis. Eur J Obstet Gynecol Reprod Biol. 11:1980;195-200.
8. Huffman J.W. Endometriosis in young teen-age girls. Pediatr Ann. 10:1981;501-506.
9. Chatman D.L., Ward A.B. Endometriosis in adolescents. J Reprod Med. 27:1982;156-160.
10. Goldstein D.P., deCholnoky C., Emans S.J., Leventhal J.M. Laparoscopy in the diagnosis and management of pelvic pain in adolescents. J Reprod Med. 24:1980;251-256.
11. Olive D.L., Schwartz L.B. Endometriosis. N Engl J Med. 328:1993;1759-1769.
12. Sampson J.A. Metastasis of embolic endometriosis due to menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 3:1927;93-109.
13. Sampson J.A. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 14:1927;422-425.
14. Halme J., Becker S., Hammond M.G., Raj M.H.G., Raj S. Increased activation of pelvic macrophages in infertile women with mild endometriosis. Fertil Steril. 145:1983;333-337.
15. Halme J., White C., Kauma S., Estes J., Haskill S. Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro. J Clin Endocrinol Metab. 66:1988;1044-1049.
16. Dmowski W.P., Steele R.W., Baker G.F. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol. 141:1981;377-383.
17. Noble L.S., Simpson E.R., Johns A., Bulun S.E. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 81:1996;174-179.
18. Zeitoun K., Takayama K., Michael M.D., Bulun S.E. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of SF-1 and COUP-TF to the same cis-acting element. Mol Endocrinol. 13:1999;239-253.
19. Khorram O., Taylor R.N., Ryan I.P., Schall T.J., Landers D.V. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol. 169:1993;1545-1549.
20. Sharpe-Timms K.L., Penney L.L., Zimmer R.L., Wright J.A., Zhang Y., Surewicz K. Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveals homology with tissue inhibitor of metalloproteinases-1 (TIMP-1). J Clin Endocrinol Metab. 80:1995;3784-3787.
21. Bruner K.L., Matrisian L.M., Rodgers W.H., Gorstein F., Osteen K.G. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest. 99:1997;2851-2857.
22. Aleem F., Pennisi J., Zeitoun K., Predanic M. The role of color Doppler in the diagnosis of endometriosis. Ultrasound Obstet Gynecol. 5:1995;51-54.
23. Osteen K.G., Bruner K.L., Sharpe-Timms K.L. Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Semin Reprod Endocrinol. 15:1996;301-308.
24. Rodgers W.H., Matrisian L.M., Giudice L.C., Dsupin B., Cannon P., Svitek C., et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest. 94:1994;946-953.
25. Bruner K.L., Rodgers W.H., Gold L.I., Korc M., Hargrove J.T., Matrisian L.M., et al. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA. 92:1995;7362-7366.
26. Osteen K.G., Rodgers W.H., Gaire M., Hargrove J.T., Gorstein F., Matrisian L.M. Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci USA. 91:1994;10129-10133.
27. Zeitoun K., Takayama K., Sasano H., Suzuki T., Moghrabi N., Andersson S., et al. Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis failure to metabolize estradiol-17β J Clin Endocrinol Metab. 83:1998;4474-4480.
28. Ryan K.J., Petro Z. Steroid biosynthesis by human ovarian granulosa and thecal cells. J Clin Endocrinol Metab. 26:1966;46-52.
29. Ryan K.J., Petro Z., Kaiser J. Steroid formation by isolated and recombined ovarian granulosa and thecal cells. J Clin Endocrinol Metab. 28:1968;355-358.
30. Sasano H., Okamoto M., Mason J.I., Simpson E.R., Mendelson C.R., Sasano N., et al. Immunolocalization of aromatase, 17α-hydroxylase and side-chain-cleavage P-450 in the human ovary. J Reprod Fertil. 85:1989;163-169.
31. Carr B.R. Disorders of the ovary and female reproductive tract. Wilson J.D., Foster D.W. Williams textbook of endocrinology. 1992;733-798 WB Saunders, Philadelphia.
32. Adashi E.Y., Resnick C.E., Brodie A.M., Svoboda M.E., VanWyck J.J. Somatomedin-C-mediated potentiation of follicle-stimulating hormone-induced aromatase activity of cultured rat granulosa cells. Endocrinology. 117:1985;2313-2320.
33. Michael M.D., Michael L.F., Simpson E.R. A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene. Mol Cell Endocrinol. 134:1997;147-156.
34. Michael M.D., Kilgore M.W., Morohashi K.-I., Simpson E.R. Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J Biol Chem. 270:1995;13561-13566.
35. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S., et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev. 15:1994;342-355.
36. Casey M.L., MacDonald P.C. Origin of estrogen and the regulation of estrogen formation in postmenopausal women. Buchsbaum H.J. The menopause. 1983;1-8 Springer-Verlag, New York.
37. Ackerman G.E., Smith M.E., Mendelson C.R., MacDonald P.C., Simpson E.R. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab. 53:1981;412-417.
38. 4-androstenedione to estrone in normal males and non-pregnant normal, castrate and adrenalectomized females. J Clin Endocrinol Metab. 27:1967;1103-1111.
39. MacDonald P.C., Edman C.D., Hemsell D.L., Porter J.C., Siiteri P.K. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol. 130:1978;448-455.
40. Carr B.R., MacDonald P.C. Cardinal manifestations of aging and disease the menopause and beyond . Andres R., Bierman E.L., Hazzard W.R. Principles of geriatric medicine. 1985;325-336 McGraw-Hill, New York.
41. MacDonald PC. Age-related aberrations in proliferative homeostasis. The role of endocrines in age-related hyperplasias and neoplasias of the endometrium and prostate: a summary statement. In: Biological mechanisms in aging. Conference proceedings. U.S. Department of Health and Human Services, National Institute on Aging, 1981:83-4.
42. MacDonald PC. Origin of estrogen in postmenopausal women at increased risk of endometrial carcinoma. In: Richardson GS, MacLaughlin DT, eds. Hormonal biology of endometrial cancer. U.I.C.C. Technical Report Series, 1978:15-35.
43. MacDonald P.C., Edman C.D., Kerber I.J., Siiteri P.K. Plasma precursors of estrogen III. Conversion of plasma dehydroisoandrosterone to estrogen in young, nonpregnant women . Gynecol Invest. 7:1976;165-175.
44. MacDonald P.C., Grodin J.M., Edman C.D., Vellios F., Siiteri P.K. Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia. Obstet Gynecol. 47:1976;644-650.
45. MacDonald P.C., Siiteri P.K. The relationship between the extraglandular production of estrone and the occurrence of endometrial neoplasia. Gynecol Oncol. 2:1974;259-263.
46. O'Neill J.S., Miller W.R. Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases. Br J Cancer. 56:1987;601-604.
47. O'Neill J.S., Elton R.A., Miller W.R. Aromatase activity in adipose tissue from breast quadrants a link with tumor site . Br Med J. 296:1988;741-743.
48. Bulun S.E., Noble L.S., Takayama K., Michael M.D., Agarwal V., Fisher C., et al. Endocrine disorders associated with inappropriately high aromatase expression. J Steroid Biochem Mol Biol. 61:1997;133-139.
49. Bulun S.E., Price T.M., Mahendroo M.S., Aitken J., Simpson E.R. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab. 77:1993;1622-1628.
50. Yue W., Wang J.P., Hamilton C.J., Demers L.M., Santen R.J. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res. 58:1998;927-932.
51. Bulun S.E., Simpson E.R., Word R.A. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human leiomyoma tissues and cells in culture. J Clin Endocrinol Metab. 78:1994;736-743.
52. 2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab. 82:1997;600-606.
53. Bulun S.E., Mahendroo M.S., Simpson E.R. Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua. J Clin Endocrinol Metab. 76:1993;1458-1463.
54. Bulun S.E., Economos K., Miller D., Simpson E.R. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. J Clin Endocrinol Metab. 79:1994;1831-1834.
55. Sasano H., Nobuhiro H. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr Rev. 19:1998;593-607.
56. Kitawaki J., Noguchi T., Amatsu T., Maeda K., Tsukamoto K., Yamamoto T., et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod. 57:1997;514-519.
57. Yamamoto T., Kitawaki J., Urabe M., Honjo H., Tamura T., Noguchi T., et al. Estrogen production of endometrium and endometrial cancer tissue influence of aromatase on proliferation of endometrial cancer cells . J Steroid Biochem Mol Biol. 44:1993;463-468.
58. Watanabe K., Sasano H., Harada N., Ozaki M., Niikura H., Sato S., et al. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Am J Pathol. 146:1995;491-500.
59. Sasano H., Okamoto M., Mason J.I., Simpson E.R., Mendelson C.R., Sasano N., et al. Immunohistochemical studies of steroidogenic enzymes (aromatase, 17α-hydroxylase and cholesterol side-chain-cleavage cytochrome P-450) in sex-cord stromal tumors of the ovary. Hum Pathol. 20:1989;452-457.
60. Kaga K., Sasano H., Harada N., Ozaki M., Sato S., Yajima A. Aromatase in human common epithelial ovarian neoplasms. Am J Pathol. 149:1996;45-51.
61. Sainz-de-la-Cuesta R., Eichhorn J.H., Rice L.W., Fuller A.F. Jr, Nikrui N., Goff B.A. Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol Oncol. 60:1996;238-244.
62. Huang J.-C., Liu D.-Y., Yadollahi S., Wu K.K., Dawood M.Y. Interleukin-1β induces cyclooxygenase-2 gene expression in cultured endometrial stromal cells. J Clin Endocrinol Metab. 83:1998;538-541.
63. Huang JC, Dawood MY, Wu KK. Regulation of cyclooxygenase-2 gene in cultured endometrial stromal cells by sex steroids [abstract]. In: Proceedings of the American Society for Reproductive Medicine Meeting: Boston, MA. October 1996.
64. Sharpe K.L., Vernon M.W. Polypeptides synthesized and released by rat ectopic uterine implants differ from those of the uterus in culture. Biol Reprod. 48:1993;1334-1340.
65. Sharpe K.L., Zimmer R.L., Griffin W.T., Penney L.L. Polypeptides synthesized and released by human endometriosis differ from those of the uterine endometrium in cell and tissue explant culture. Fertil Steril. 60:1993;839-851.
66. Hill J.A. Immunology and endometriosis. Fertil Steril. 58:1992;262-264.
67. Hill J., Anderson D. Lymphocyte activity in the presence of peritoneal fluid from fertile women and infertile women with and without endometriosis. Am J Obstet Gynecol. 161:1989;861-864.
68. Steele W.R., Dmowski W.P., Marmer D.J. Immunologic aspects of human endometriosis. Am J Obstet Gynecol. 6:1984;33-36.
69. Halme J., Hammond M.G., Hulka J.F., Raj S.G., Talbert L.M. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol. 64:1984;151-154.
70. Mathur S., Peress M.R., Williamson H.O. Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol. 50:1982;259-266.
71. Takayama K., Zeitoun K., Gunby R.T., Sasano H., Carr B.R., Bulun S.E. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril. 69:1998;709-713.
72. Ackerman G.E., MacDonald P.C., Gudelsky G., Mendelson C.R., Simpson E.R. Potentiation of epinephrine-induced lipolysis by catechol estrogens and their methoxy derivatives. Endocrinology. 109:1981;2084-2088.
73. MacDonald P.C. Determinants of the rate of estrogen formation in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 9:1979;187-189.
74. MacDonald PC, Grodin JM, Siiteri PK. The utilization of plasma androstenedione for estrone production in women. In: Excerpta Medica International Congress series no. 184, progress in endocrinology. Proceedings of the Third International Congress of Endocrinology (Mexico). 1968:770-6.
75. Gurpide E., MacDonald P.C., Chapdelaine A., VandeWiele R.L., Lieberman S. Studies on the secretion and interconversion of the androgens. II. Methods for estimation of rates of secretion and of metabolism from specific activities of urinary metabolites. J Clin Endocrinol Metab. 25:1965;1537-1556.
76. Labrie F., Luu-The V., Labrie C., Bérubé D., Couet J., Zhao H.-F., et al. Characterization of two mRNA species encoding human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17. J Steroid Biochem. 34:1989;189-197.
77. Labrie Y., Durocher F., Lachance Y., Turgeon C., Simard J., Labrie C., et al. The human type II 17β-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA species. DNA Cell Biol. 14:1995;849-861.
78. Wu L., Einstein M., Geissler W.M., Chan H.K., Elliston K.O., Andersson S. Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem. 268:1993;12964-12969.
79. Andersson S., Moghrabi N. Physiology and molecular genetics of 17β-hydroxysteroid dehydrogenases. Steroids. 62:1997;143-147.
80. Casey M.L., MacDonald P.C., Andersson S. 17β-Hydroxysteroid dehydrogenase type 2 chromosomal assignment and progestin regulation of gene expression in human endometrium . J Clin Invest. 94:1994;2135-2141.
81. Satyaswaroop P.G., Wartell D.J., Mortel R. Distribution of progesterone receptor, estradiol dehydrogenase, and 20α-dihydroprogesterone dehydrogenase activities in human endometrial glands and stroma progestin induction of steroid dehydrogenase activities in vitro is restricted to the glandular epithelium . Endocrinology. 111:1982;743-749.
82. Tseng L., Gurpide E. Estradiol and 20α-dihydroprogesterone dehydrogenase activities in human endometrium during the menstrual cycle. Endocrinology. 94:1974;419-423.
83. Vernon M.W., Wilson E.A. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 44:1985;684-694.
84. Zamah N.M., Dodson M.G., Stephens L.C., Buttram V.C. Jr, Besch P.K., Kaufman R.H. Transplantation of normal and ectopic human endometrial tissue into athymic nude mice. Am J Obstet Gynecol. 149:1984;591-597.
85. Cooke P.S., Buchanan D.L., Young P., Setiawan T., Brody J., Korach K.S., et al. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci USA. 94:1997;6535-6540.
86. Cooke P.S., Buchanan D.L., Lubahn D.B., Cunha G.R. Mechanism of estrogen action lessons from the estrogen receptor-α knockout mouse . Biol Reprod. 59:1998;470-475.
87. Henzl M.R., Corson S.L., Moghissi K., Buttram V.C., Berqvist C., Jacobson J. Administration of nasal nafarelin as compared with oral danazol for endometriosis. N Engl J Med. 318:1988;485-489.
88. Waller K.G., Shaw R.W. Gonadotropin-releasing hormone analogues for the treatment of endometriosis long-term follow-up . Fertil Steril. 59:1993;511-515.
89. Metzger D.A., Lessey B.A., Soper J.T., McCarty K.S. Jr, Haney A.F. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy correlation with histology and steroid receptor content . Obstet Gynecol. 78:1991;946-950.